BACKGROUND: Bisphenol F (BPF) is a common substitute for bisphenol A and the most prevalent bisphenol compound in diverse ...
Cardiac intensive care units are specialized, high-acuity, and resource-intensive environments for the care of critically ill ...
Resources for observational comparative research have expanded enormously in recent years to include very large sources of ...
BACKGROUND: Heart failure with reduced ejection fraction (HFrEF) is characterized by impaired contractility and high ...
BACKGROUND: The optimal transfusion strategy in patients with acute myocardial infarction (AMI) and anemia may be influenced by sex differences in pathophysiology and cardiovascular outcomes. The ...
Department of Medicine, NYC Health + Hospitals/Jacobi, Bronx, NY. (Y.-Y.C., P.B., L.B., N.N., M.P., A.K., C.V.-P., I.C., J.B., V.G., S.B., R.F., L.P.) Division of ...
This article category consists of high-quality randomized clinical trials conducted in the U.S. or globally. Authors can expect broad dissemination and expert contextualization across multi-media ...
Publishing research with negative results—that is, null or inconclusive findings—is a critical but often overlooked task of biomedical journals. Without it, the scientific literature relies on highly ...
The American Heart Association/American Stroke Association journals are continuing to serve authors of Original Research manuscripts by offering additional means of publication. Many research funding ...
The time limit for receipt of revisions is dated from the most recent decision letter: Original Research Article — 90-day revision time. Research Letter — 90-day revision time. All other article ...
Background: Stenosis and dolichoectasia of cranial arteries likely reflect distinct mechanisms. Their contributions to lacunar stroke and cerebral small-vessel disease (cSVD) remain contentious. We ...
Background: Atrial functional mitral regurgitation (AFMR) characterizes a high-risk phenotype in heart failure with preserved ejection fraction (HFpEF). Although sacubitril/valsartan reduces ...